Literature DB >> 15476632

Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy).

Michael H Olsen1, Kristian Wachtell, Jonathan N Bella, Jennifer E Liu, Kurt Boman, Eva Gerdts, Vasilios Papademetriou, Markku S Nieminen, Jens Rokkedal, Björn Dahlöf, Richard B Devereux.   

Abstract

Neither losartan- nor atenolol-based antihypertensive regimens could prevent the progression of aortic valve (AV) sclerosis in elderly, high-risk hypertensive patients, and the regression of AV sclerosis did not translate into reduced cardiovascular risk.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15476632     DOI： 10.1016/j.amjcard.2004.06.074

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  9 in total

1.  Observational and Genetic Associations of Resting Heart Rate With Aortic Valve Calcium.

Authors:  Seamus P Whelton; Andreas C Mauer; Karol M Pencina; Joseph M Massaro; Ralph B D'Agostino; Caroline S Fox; Udo Hoffmann; Erin D Michos; Gina M Peloso; Line Dufresne; James C Engert; Sekar Kathiresan; Matthew Budoff; Wendy S Post; George Thanassoulis; Christopher J O'Donnell
Journal:  Am J Cardiol       Date:  2018-02-13       Impact factor: 2.778

2.  Derivation of a simplified relation for assessing aortic root pressure drop incorporating wall compliance.

Authors:  Hossein Mohammadi; Raymond Cartier; Rosaire Mongrain
Journal:  Med Biol Eng Comput       Date:  2014-11-28       Impact factor: 2.602

Review 3.  Potential drug targets for calcific aortic valve disease.

Authors:  Joshua D Hutcheson; Elena Aikawa; W David Merryman
Journal:  Nat Rev Cardiol       Date:  2014-01-21       Impact factor: 32.419

Review 4.  Aortic sclerosis: not an innocent murmur but a marker of increased cardiovascular risk.

Authors:  A K Nightingale; J D Horowitz
Journal:  Heart       Date:  2005-03-29       Impact factor: 5.994

5.  The effect of aortic wall and aortic leaflet stiffening on coronary hemodynamic: a fluid-structure interaction study.

Authors:  S Nobari; R Mongrain; R Leask; R Cartier
Journal:  Med Biol Eng Comput       Date:  2013-04-03       Impact factor: 2.602

6.  5-HT(2B) antagonism arrests non-canonical TGF-β1-induced valvular myofibroblast differentiation.

Authors:  Joshua D Hutcheson; Larisa M Ryzhova; Vincent Setola; W David Merryman
Journal:  J Mol Cell Cardiol       Date:  2012-08-23       Impact factor: 5.000

Review 7.  Epidemiology and cardiovascular risk factors of aortic stenosis.

Authors:  Pompilio Faggiano; Francesco Antonini-Canterin; Ferdinando Baldessin; Roberto Lorusso; Antonio D'Aloia; Livio Dei Cas
Journal:  Cardiovasc Ultrasound       Date:  2006-07-01       Impact factor: 2.062

Review 8.  The Genetic Regulation of Aortic Valve Development and Calcific Disease.

Authors:  Vinal Menon; Joy Lincoln
Journal:  Front Cardiovasc Med       Date:  2018-11-06

9.  Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments.

Authors:  Kristina Yeghiazaryan; Dirk Skowasch; Gerhard Bauriedel; Hans H Schild; Olga Golubnitschaja
Journal:  EPMA J       Date:  2011-04-03       Impact factor: 6.543
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.